1. Home
  2. NBR vs SPTX Comparison

NBR vs SPTX Comparison

Compare NBR & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nabors Industries Ltd.

NBR

Nabors Industries Ltd.

HOLD

Current Price

$81.63

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$21.25

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBR
SPTX
Founded
1952
N/A
Country
Bermuda
United States
Employees
13900
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
NBR
SPTX
Price
$81.63
$21.25
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$75.00
N/A
AVG Volume (30 Days)
282.1K
206.6K
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.65
N/A
Revenue Next Year
$4.88
N/A
P/E Ratio
$4.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.50
$17.59
52 Week High
$112.90
$22.98

Technical Indicators

Market Signals
Indicator
NBR
SPTX
Relative Strength Index (RSI) 41.67 62.35
Support Level $75.43 $17.89
Resistance Level $83.77 $21.59
Average True Range (ATR) 3.47 1.88
MACD -0.05 0.06
Stochastic Oscillator 50.57 68.80

Price Performance

Historical Comparison
NBR
SPTX

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: